RecruitingNot ApplicableNCT07005050

Renal Pelvic Denervation Pilot Trial


Sponsor

Verve Medical, Inc

Enrollment

60 participants

Start Date

Dec 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medications at a therapeutic dose. The novelty of the RPDTM system relates to its placement via natural orifice into the renal pelvis (bilaterally) for delivery of radiofrequency energy to ablate the nerves that pass through the outer wall of the renal pelvis, a technique referred to as renal pelvic denervation (RPD).


Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is testing a new procedure called renal pelvic denervation — which uses energy to disrupt nerve signals from inside the kidney — as a way to lower blood pressure in people whose hypertension is not well controlled on medication. **You may be eligible if...** - You are currently taking 2 blood pressure medications (one should be an ACE inhibitor, ARB, or renin inhibitor; the other a calcium channel blocker or diuretic) - Your blood pressure medications have been stable for at least 30 days - Your daytime blood pressure readings are in a specific elevated range (systolic 135–170 mmHg, diastolic under 105 mmHg) - Your office blood pressure is between 140 and 180 mmHg systolic **You may NOT be eligible if...** - You have a history of atrial fibrillation (an irregular heartbeat) - You are pregnant, breastfeeding, or planning to become pregnant - Your blood pressure is extremely high (≥ 180/110 mmHg) - You have an untreated urinary tract infection - You have kidney structural problems (such as kidney stones, hydronephrosis, or duplicated collecting system) - You are on dialysis or have had a kidney transplant - You have only one functioning kidney Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERPD

Renal Pelvic Denervation

DRUGActive hypertension medical therapy

Prespecified two medication regimen for control of hypertension


Locations(5)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Panoramic Health / Southwest Kidney Institute, PLC

Surprise, Arizona, United States

University of Minnesota

Minneapolis, Minnesota, United States

Mayo Clinic

Rochester, Minnesota, United States

DaVita Clinical Research

Las Vegas, Nevada, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07005050


Related Trials